HBT vs RARE · P/E 11, rev $160.4M vs rev $350.0M
Hbt Financial Inc (HBT) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Hbt Financial Inc (HBT) is a banks - regional company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported HBT revenue for 2026-06-30 was $160.4M. Net income was $39.0M. HBT currently screens at market cap $828.6M and trailing P/E 10.8.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
HBT currently screens at market cap $828.6M and trailing P/E 10.8. RARE currently screens at market cap $2.79B.
Not investment advice. Open the HBT and RARE stock pages for the full models.
Not investment advice.